Literature DB >> 9926925

Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells.

H Yamamoto1, J W Soh, H Shirin, W Q Xing, J T Lim, Y Yao, E Slosberg, N Tomita, I Schieren, I B Weinstein.   

Abstract

Recent studies have shown that decreased expression of p27Kip1 is associated with high grade tumors and an unfavorable prognosis in several types of human cancer. To clarify the role of p27Kip1 in colon cancer, we have overexpressed this protein in the HT29 colon cancer cell line. The derivatives displayed an increase in the p27Kip1 protein in cyclin E/CDK2 immunoprecipitates and a decrease in cyclin E-associated kinase activity when compared to vector control clones, providing evidence that the overexpressed protein was functional. Clones with a high level of p27Kip1 displayed partial growth inhibition in monolayer culture and a decrease in plating efficiency, even though they expressed increased levels of the cyclin D1 protein. Using alkaline phosphatase expression as a marker, we found that the p27Kip1 overexpressor clones displayed a 2-3-fold increase in sensitivity to induction of differentiation by 2 mM sodium butyrate. In contrast to these results, derivatives of HT29 cells that stably overexpressed p21Cip1/Waf1 displayed decreased sensitivity to the induction of differentiation. These findings may explain why decreased levels of p27Kip1 in certain human cancers is associated with high grade (poorly differentiated) tumors, and suggest that strategies that increase the level of p27Kip1 may be useful in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9926925     DOI: 10.1038/sj.onc.1202269

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Comparison of the expression of p53, p21, Bax and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation.

Authors:  M Murphy; M J E M F Mabruk; P Lenane; A Liew; P McCann; A Buckley; C O Flatharta; D Hevey; P Billet; W Robertson; S Javed; M Leader; E Kay; G M Murphy
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

2.  Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.

Authors:  Jason R Gee; Corrie B Burmeister; Thomas C Havighurst; Kyungmann Kim
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

3.  Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states.

Authors:  K Wesley Overton; Sabrina L Spencer; William L Noderer; Tobias Meyer; Clifford L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

4.  Activation of cyclin E-dependent kinase activity in colorectal cancer.

Authors:  W R Cam; T Masaki; T Y Shiratori; N Kato; M Okamoto; Y Yamaji; K Igarashi; T Sano; M Omata
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

5.  p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.

Authors:  S Walsh; M Murphy; M Silverman; R Odze; D Antonioli; H Goldman; M Loda
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

6.  The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein.

Authors:  Yi Zhao; Gen Zhang; Mengying Wei; Xiaozhao Lu; Hanyan Fu; Feixue Feng; Shan Wang; Wei Lu; Ning Wu; Zifan Lu; Jianlin Yuan
Journal:  Cancer Biol Ther       Date:  2013-10-23       Impact factor: 4.742

7.  RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer.

Authors:  Guodong Yang; Haiyan Fu; Jie Zhang; Xiaozhao Lu; Fang Yu; Liang Jin; Liyuan Bai; Bo Huang; Lan Shen; Yue Feng; Libo Yao; Zifan Lu
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

8.  Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium.

Authors:  M R Frey; J A Clark; O Leontieva; J M Uronis; A R Black; J D Black
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

9.  Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology.

Authors:  O Takayama; H Yamamoto; B Damdinsuren; Y Sugita; C Y Ngan; X Xu; T Tsujino; I Takemasa; M Ikeda; M Sekimoto; N Matsuura; M Monden
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

10.  Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.

Authors:  K Nishioka; Y Doki; H Shiozaki; H Yamamoto; S Tamura; T Yasuda; Y Fujiwara; M Yano; H Miyata; K Kishi; H Nakagawa; A Shamma; M Monden
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.